Concerns Expressed by Chinese Social Media Users During the COVID-19 Pandemic: Content Analysis of Sina Weibo Microblogging DataCOVID-19 전염병 동안 중국 소셜 미디어 사용자가 표현한 우려: Sina Weibo 마이크로블로깅 데이터의 콘텐츠 분석Original Paper Published on 2020-11-262022-09-10 Journal: Journal of Medical Internet Research [Category] SARS, 치료기술, [키워드] affecting Analysis analyzed Behavior calculated changes in China Chinese citizen concerns collected Community concern content coronavirus Coronavirus pneumonia correlated country COVID-19 COVID-19 pandemic COVID-19 treatments disseminate distribution eligible emotional emotional support Epidemic Epidemics Evolution expressed expressing global pandemic Government Health Health crisis help highest identify individuals information joint latent Dirichlet allocation media Medical resources Metadata New New coronavirus objective organization organizations pandemic Participation performed platform Pneumonia positive Prevention and control provided Psychological public health public opinion quarantine raised Region Research Result Shock Sina Weibo social media social media platform social media platforms Topic user Vaccine development web crawler [DOI] 10.2196/22152 PMC 바로가기 [Article Type] Original Paper
Moving singing for lung health online in response to COVID-19: experience from a randomised controlled trialCOVID-19에 대응하여 폐 건강을 위한 온라인 노래 이동: 무작위 대조 시험의 경험Randomized Controlled Trial Published on 2020-11-252022-08-09 Journal: BMJ Open Respiratory Research [Category] 임상, [키워드] ABC ABC scale points actigraphy activity adaptation Anxiety Anxiety Disorder assessment Attendance balance balance confidence benefit biopsychosocial benefits blind breathlessness chronic obstructive chronic obstructive pulmonary disease chronic obstructive pulmonary disease (COPD) complementary medicine conducted confidence controls COPD COPD Assessment Test score COVID-19-related physical distancing COVID-19-related physical distancing measures Depression digital barrier digital barriers digital facilitator digital facilitators disease Dyspnoea exercise experience face-to-face sessions facilitator facilitators finding FIVE form Generalised anxiety disorder Generalised Anxiety Disorder-7 Health help identify improvement Improving include key consideration key considerations life long-term respiratory conditions lung Lung disease Measures Medical Research Council nine obstructive pulmonary disease online delivery online group singing online sessions participant Participation participation in SLH people with COPD PHQ-9 physical activity physical distancing measures Pilot quantitative data Pilot quantitative outcome Pilot quantitative outcomes pilot study postmeasure postmeasures premeasure premeasures Proactive pulmonary disease Quality of life randomised controlled randomised controlled trial reducing reported Research respiratory Result semistructured interview semistructured interviews setup Seven singing singing group singing groups suggested survey Test thematic analysis Treatment Trial usual care [DOI] 10.1136/bmjresp-2020-000737 PMC 바로가기 [Article Type] Randomized Controlled Trial
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trialCOVID-19(IVERCOR-COVID19) 환자의 입원을 방지하기 위한 Ivermectin: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Randomized Controlled Trial Published on 2020-11-242022-08-13 Journal: Trials [Category] SARS, 임상, 치료기술, [키워드] 1:1 acute infectious disease addition adherence administration Admission adverse event adverse events age allergy analyzed Anthropometric data antiviral drug antiviral drugs Arm ARMS assessment barrier basal blinded Breastfeeding breastfeeding women Cardiology Care care providers carried cause Chain Reaction childbearing age Chloroquine cirrhosis component components Concomitant Concomitant medication Confirmed connection contraceptive method contraceptives Control control group control groups coordination Corriente COVID-19 COVID-19 patient population criteria current Day death demographic demographic data Diagnosis diagnosis of COVID-19 dialysis discharged dissemination dose double-blind drug Efficacy Efficacy and safety elapsed element EOS Equal example exclusion criteria Final final visit first dose Follow-up greater heart rate Hospitalization hospitalizations Hydroxychloroquine incidence include Inclusion inclusion criteria inclusion/exclusion criteria Informed consent Intervention Invasive mechanical ventilation investigator investigators Ivermectin Ivermectin safety Laboratory less liver Liver cirrhosis Liver disease mal-absorptive syndrome medical history medication menstrual menstrual cycles Mortality negative Negative PCR number objective outcome outcome assessor outcome assessors over oxygen oxygen saturation parallel group participant Participants Participation Patient patients with COVID-19 PCR PCR swab Placebo placebo-controlled study polymerase chain polymerase chain reaction Polymerase chain reaction test postmenopausal pregnant Presence Prevent Primary outcome protocol Public public health randomization Randomized Randomized controlled trial randomly permuted blocks receive recommendation recorded recruitment reducing renal replacement therapy replacement therapy reproductive required Research Sample size SARS-CoV2 secondary severe liver disease single-center standard treatment standard treatment alone Study protocol supplementary material surgical Swab table Tablet temperature the patient Total Treatment Trial Trial registration use of hydroxychloroquine Version Viral viral pathology Vital vital signs vital status web system website weight woman women [DOI] 10.1186/s13063-020-04813-1 PMC 바로가기 [Article Type] Randomized Controlled Trial
Rapid establishment of a national surveillance of COVID-19 hospitalizations in BelgiumMethodology Published on 2020-11-182022-10-27 Journal: Archives of Public Health [Category] COVID-19, [키워드] Admission approach Belgium Capacity caused Characteristics clinical complementary COVID-19 COVID-19 epidemic COVID-19 hospitalization COVID-19 patient discharge disease epidemiological group health authorities Health authority hospital Hospital capacity Hospital outcome Hospital-based surveillance Hospitalized hospitals incidence include information management mandatory MONITOR National Novel coronavirus occupancy rate outcomes Participation Patient patient data Prevalence provided public health threat Rapid risk severity supplementary material Support Surveillance the disease [DOI] 10.1186/s13690-020-00505-z PMC 바로가기 [Article Type] Methodology
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany독일의 슈퍼확산 사건에서 SARS-CoV2의 감염 치사율Article Published on 2020-11-172022-09-12 Journal: Nature Communications [Category] SARS, 유전자 메커니즘, 진단, [키워드] Affect Analysis Asymptomatic Characteristics Community consequence determined by Epidemiology Fatality rate Germany Healthcare system IFR IgG increase individual infected individual Infection infection rate information lockdown number of symptom observational study occurred pandemic Participation PCR testing random reported SARS-CoV-2 SARS-CoV2 severity study population viral infection was determined was performed were infected while [DOI] 10.1038/s41467-020-19509-y PMC 바로가기 [Article Type] Article
COVID-19: Pitfalls in Offering Research Participation as Therapy in Clinical SettingsCOVID-19: 임상 환경에서 치료로 연구 참여를 제공할 때의 함정Editorial Published on 2020-11-012022-09-11 Journal: Journal of General Internal Medicine [Category] SARS, 임상, [키워드] clinical Offering Participation setting [DOI] 10.1007/s11606-020-06158-6 PMC 바로가기 [Article Type] Editorial
[Confined community health: Reflections and experiences from the local public health]Article Published on 2020-10-302023-07-06 Journal: Revista Latino-Americana de Enfermagem [Category] SARS, [키워드] community health COVID-19 Intersectoral work Participation Spain
The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trialCOVID-19 환자의 치료 보조제로 커큐민을 함유한 나노 미셀의 임상 효과 및 치료 후 면역 반응 균형 변화: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2020-10-222022-08-13 Journal: Trials [Category] MERS, SARS, 임상, [키워드] 1:1 accompany addition allergy assigned balance Bandar Abbas bedtime blind Blinding both groups breakfast Capsule change Characteristics chronic chronic obstructive pulmonary disease clinical Clinical effect clinical examination clinical examinations clinical symptom clinical trial clinical trials Comorbidities Comorbidity company comparator Complete computer conducted congestive heart failure control group COVID-19 COVID-19 patient COVID-19 patients Curcumin Cytokines digit digits dinner dissemination Effectiveness element evaluate evaluated expected expression filtration filtration rate FOXP3 gallstone gastritis GATA Gender Gene Expression glomerular filtration rate heart failure history IFN-γ IL-17 IL-4 immune response immune responses in both group inclusion criteria Inflammatory marker inflammatory markers information Interleukins intervention group Iran kPa Laboratory laboratory findings laboratory technician laboratory technicians lactation less liver liver failure Lymphocytes number Nurses objective Obstructive obstructive pulmonary disease outcome PaO2 parallel group participant Participation Patient patients patients with COVID-19 per day performed Peripheral blood physician Placebo placebo group placebo-controlled positive COVID-19 post treatment Pregnancy protocol pulmonary disease random randomisation randomised randomised controlled trial randomization Randomized randomized clinical trial Randomly real time PCR recorded recruitment Registered registry Regulatory renal renal failure routine standard treatment Sample size sealed selected serum cytokine serum cytokines Serum level serum parameter serum parameters shift single-center statisticians Study protocol T helper TGF-β the placebo group therapeutic Treatment Trial Trial registration ventilator Version website written consent [DOI] 10.1186/s13063-020-04824-y PMC 바로가기 [Article Type] Letter
Study on the Relationship between Leisure Activity Participation and Wearing a Mask among Koreans during COVID-19 Crisis: Using TPB ModelArticle Published on 2020-10-212022-10-30 Journal: International Journal of Environmental Research an [Category] Coronavirus, MERS, SARS, [키워드] activities activity age analyses Behavior collected data conducted COVID-19 Factor Health individual influence Intention Korean leisure mandatory Mask Model Multiple linear regression non-physical activity participated Participation physical physical activity positive attitude promote regions relationship Respiratory disease Sex stratified theory Theory of Planned Behavior wearing wearing a mask [DOI] 10.3390/ijerph17207674 PMC 바로가기 [Article Type] Article
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial이중 맹검, 무작위, 위약 대조 임상 3상 임상 시험을 통해 의료 전문가를 Sinovac에서 제조한 흡착된 COVID-19(불활성화) 백신으로 치료하는 효과와 안전성을 평가합니다. – PROFISCOV: 무작위 대조를 위한 연구 프로토콜의 구조화된 요약 재판Letter Published on 2020-10-152022-08-13 Journal: Trials [Category] MERS, SARS, 임상, [키워드] 95% confidence interval Active surveillance adjuvant Administered administration Adults adverse event adverse events Adverse reaction Adverse reactions age Aluminium aluminium hydroxide Analysis attack rate Beijing blind Blinding Brazil Breastfeeding calculated Care causal relationship China clinical clinical care clinically Committee completion confirmed case Consent consent form Contact contact with Control COVID-19 criterion database defined Diagnosis direct contact disease dissemination dose double-blind double-blind study Efficacy Efficacy and safety elderly element Endpoint evaluate exclusion criteria expected experimental intervention FDA form Frequency genders Health Health Organization hydroxide immunogenicity inactivated Inactivated Vaccines incidence include Inclusion information Informed intramuscular dose life limit Local monitoring multicenter nucleic acid number Nurse Nurses objective Occurrence Older outcome participant Participants Participation Patient phase Phase III Clinical Trial Placebo placebo-controlled clinical trial pregnant pregnant women primary efficacy endpoint produced product professional professionals protocol randomisation randomised randomised controlled trial randomization randomization list randomization system Randomized receive recruitment regimen registry responsible retained Safety Sample size SARS-CoV-2 nucleic acid SARS-CoV-2 virus schedule second vaccination separation Sinovac Sinovac Life Science Sinovac Life Sciences Sponsor status stratified Study protocol subjects symptomatic case symptomatic cases symptomatic individuals systemic adverse reaction systemic adverse reactions the vaccine threshold Trial Trial registration undergo vaccination Vaccine Virological voluntary website World Health Organization [DOI] 10.1186/s13063-020-04775-4 PMC 바로가기 [Article Type] Letter